000 | 01586 a2200517 4500 | ||
---|---|---|---|
005 | 20250513160039.0 | ||
264 | 0 | _c19981221 | |
008 | 199812s 0 0 eng d | ||
022 | _a0146-0404 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStitt, A W | |
245 | 0 | 0 |
_aAdvanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy. _h[electronic resource] |
260 |
_bInvestigative ophthalmology & visual science _cDec 1998 |
||
300 |
_a2517-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCollagen _xdrug effects |
650 | 0 | 4 |
_aDiabetic Retinopathy _xmetabolism |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucose _xpharmacology |
650 | 0 | 4 |
_aGlycation End Products, Advanced _xmetabolism |
650 | 0 | 4 |
_aGuanidines _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicroscopy, Immunoelectron |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aVitrectomy |
650 | 0 | 4 |
_aVitreous Body _xmetabolism |
700 | 1 | _aMoore, J E | |
700 | 1 | _aSharkey, J A | |
700 | 1 | _aMurphy, G | |
700 | 1 | _aSimpson, D A | |
700 | 1 | _aBucala, R | |
700 | 1 | _aVlassara, H | |
700 | 1 | _aArcher, D B | |
773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 39 _gno. 13 _gp. 2517-23 |
|
999 |
_c9819842 _d9819842 |